학술논문

Initial results from the Phase I study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors
Document Type
Journal
Source
CANCER RESEARCH; JUL 2019, 79 13, 2p. Supplement: S
Subject
Language
English
ISSN
15387445